Stonepine Capital Management
$131M 13F equity value
84 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Stonepine Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| VSTM | VERASTEM INC | 3,349,627 | $13M | 9.8% |
| EOLS | EVOLUS INC | 1,590,162 | $11M | 8.4% |
| TENX | TENAX THERAPEUTICS INC | 660,000 | $10M | 7.3% |
| NKTR | NEKTAR THERAPEUTICS | 120,654 | $8M | 6.4% |
| ADMA | ADMA BIOLOGICS INC | 740,000 | $6M | 4.7% |
| CAMP | CAMP4 THERAPEUTICS CORP | 1,389,622 | $6M | 4.6% |
| ELOX | ELOXX PHARMACEUTICALS INC | 397,160 | $6M | 4.2% |
| KZIA | KAZIA THERAPEUTICS LTD | 345,179 | $5M | 3.7% |
| INDV | INDIVIOR PHARMACEUTICALS INC | 100,000 | $4M | 3.1% |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 425,000 | $4M | 3.1% |
Track Stonepine Capital Management's 13F portfolio: $131M in reported holdings, 84 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}